NCT02175784View on ClinicalTrials.gov

A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus

PHASE4CompletedINTERVENTIONAL
Enrollment

262

Participants

Timeline

Start Date

March 31, 2014

Primary Completion Date

March 31, 2015

Study Completion Date

December 7, 2015

Conditions
Type 2 Diabetes Mellitus
Interventions
DRUG

ipragliflozin

oral

DRUG

placebo

oral

Trial Locations (8)

Unknown

Chugoku

Chūbu

Hokkaido

Kansai

Kanto

Kyushu

Shikoku

Tōhoku

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY

NCT02175784 - A Study to Assess the Efficacy and Safety of Ipragliflozin in Combination With Insulin in Subjects With Type 2 Diabetes Mellitus | Biotech Hunter | Biotech Hunter